Alignment for Progress: 
A National Strategy for Mental Health and Substance Use Disorders

It’s time for a meaningful national conversation about mental health and substance use care. We must remove the barriers to equitable and available coverage for these conditions so people can get the help they need.

Welcome To The 
National Strategy

Want to understand more about the importance of building a National Strategy for Mental Health & Substance Use Disorders?

How Content Is Organized and How Best to Search/Sort the Recommendations

The National Strategy recommendations are organized by category, with impacted populations and topical areas providing additional nuance and the ability to narrow a search. We have also included the option to search recommendations by the relevant House and Senate committees of jurisdiction.

Recommendation Selection Methodologies and Criteria

After conducting a thorough review of the federal policy landscape, The Kennedy Forum team created this first-of-its-kind compilation of policy recommendations needed to transform our mental health and substance use systems. The recommendations have been sourced and vetted from numerous organizations, advocates, and experts across the country in order to capture a robust set of recommendations for lawmakers and federal agencies to act on.

All National Strategy Recommendations

These featured recommendations are highlighted based on their importance in beginning the national movement towards better care for everyone.

submit
Clear All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Clear all
Topics
Areas of Focus
Population
Federal Department
Social Determinants of Health
Coverage & Standards
House Committees
Senate Committees
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
LOADING more RECOMMENDATIONS
No results found.
If you see a loading symbol on your screen, more results are on the way! Otherwise, try different search/filter criteria.

Reinstitute the Arrestee Drug Abuse Monitoring program

The Administration should reinstitute the Arrestee Drug Abuse Monitoring (ADAM) program to improve data collection and provide resources for other promising surveillance systems.[1]

In 1998, the National Institute of Justice (NIJ) launched the Arrestee Drug Abuse Monitoring (ADAM) program to expand and restructure[2] its predecessor, the Drug Use Forecasting program, which was in place from 1987-1997.[3] ADAM collected data from adult male arrestees to help monitor drug use trends.[4] ADAM provided an objective biological measure of drug use and self-reported use among those arrested and charged with crimes.[4] The NIJ collected ADAM data between 1998-2003[4] and the Office of National Drug Control Policy reinstated ADAM data collection (as ADAM II) in 2007 with a reduced number of data collection sites.[4] ADAM data has not been collected since 2013, when the program was discontinued.

Data informs decisions in public health by tracking better, faster, and more actionable insights.[5] Centralized data collection repositories like ADAM aid in sharing outcomes, trends, and insights in addressing drug use within this population. ADAM data provided critical information for policymakers at local and federal levels to assess trends of use and impact of public programs.[6]

Topics

social determinants of health

Population

coverage & Standards

Federal Department

house committees

Senate committees

Pass the STRIP Act

Congress should pass the STRIP Act to amend the Controlled Substances Act (CSA) to exempt individuals from punishment for the possession, sale, or purchase of fentanyl drug testing equipment.

Fentanyl test strips are small strips of paper that can detect the presence of fentanyl in multiple kinds of drugs.[1] In 2021, overdose deaths due to fentanyl rose 26 percent from the previous year, reaching over 67,000.[2] The rapid rise in fentanyl-related deaths has been driven by the increasing presence of fentanyl in many drugs. The Drug Enforcement Administration (DEA) has reported a rapid rise in fentanyl-laced pills that can appear legitimate that, in fact, contain a potentially lethal amount of fentanyl.[3] In April 2023, the Biden Administration announced a multi-factored approach to disrupt fentanyl supply chains into the United States.[4] However, the problem remains that fentanyl testing strips are illegal in a handful of states.[5] The CDC recommends test strips as a means of saving lives and preventing drug overdoses.[1] Congress should pass the bipartisan STRIP Act to remove fentanyl test strips from the CSA, as well as increase funding to public health agencies to scale up the range of public health approaches, including fentanyl test strips, that are critical to saving lives.[6]

Topics

social determinants of health

Population

coverage & Standards

Federal Department

house committees

Senate committees

Have a Question About the Strategy? Want to Get Involved?

If you'd like to provide input to future iterations of the National Strategy, ask a question about our recommendations, or make an organizational commitment to the Alignment for Progress, please reach out today.

Diverse Workforce
Research & Technology
Parity, Coverage, & Equitable Access
Emergency & Crisis Response
Prevention, Early Intervention, & Youth
Infrastructure
Environmental Justice
Employment
Transportation
Education
Food Security
Housing Security
Economic Security
Youth
Women
Veterans
Sexual and Gender Minorities/LGBTQ+
Legal System-Involved Individuals
Rural Communities
People with Physical Disabilities
Older Adults
People with Intellectual & Developmental Disabilities (IDD)
Immigrants/Refugees
Hispanic/Latino
Black/African American
People with Autism
Asian American, Native Hawaiian, and Pacific Islander (AANHPI)
American Indian/Alaskan Native
Active Military
Federal Employee Health Plans
TRICARE
Individual ACA Plans
Employer Sponsored Plans
CHIP
Medicare
Medicaid
Support Services
Telehealth
Integration
Measurement-based Care
Value-based Care
Remedies for Violations
Network Adequacy/Timely Access
Medical Necessity Determinations
Covered Benefits
Parity/Treatment Limitations
Department of Transportation (DOT)
Veterans Affairs
Treasury
Labor
Justice
Housing and Urban Development (HUD)
Homeland Security
Health and Human Services
Executive Office of the President (EOP)
Education
Defense
Commerce
Agriculture
House Science, Space, and Technology Committee
House Ways and Means Committee
House Veterans' Affairs Committee
House Transportation and Infrastructure Committee
House Small Business Committee
House Foreign Affairs Committee
House Oversight and Accountability Committee
House Natural Resources Committee
House Judiciary Committee
House Homeland Security Committee
House Financial Services Committee
House Appropriations Committee
House Agriculture Committee
House Education and Workforce Committee
House Budget Committee
House Energy and Commerce Committee
House Armed Services Committee
Senate Agriculture, Nutrition, and Forestry Committee
Senate Judiciary Committee
Senate Veterans' Affairs Committee
Senate Special Committee on Aging
Senate Small Business and Entrepreneurship Committee
Senate Finance Committee
Senate Indian Affairs Committee
Senate Homeland Security and Governmental Affairs Committee
Senate Foreign Relations Committee
Senate Health, Education, Labor, and Pensions Committee
Senate Environment and Public Works Committee
Senate Armed Services Committee
Senate Commerce, Science and Transportation Committee
Senate Budget Committee
Senate Appropriations Committee
Senate Banking, Housing, and Urban Affairs Committee
Senate Energy and Natural Resources Committee